chimerix jazz - Search News

Jazz, Chimerix

Jazz Offers to Buy Chimerix for $935M to Boost Oncology Portfolio

Jazz Pharmaceuticals JAZZ announced that it has entered into a definitive agreement to acquire all the outstanding shares of clinical-stage biotech Chimerix CMRX for $8.55 per share in cash, aggregating to nearly $935 million.

Fierce Biotech · 3d

Jazz hands over $935M to buy Chimerix for near-approval cancer drug

Jazz Pharmaceuticals has drummed up a deal in double time, agreeing to buy Chimerix for $935 million just days after its CEO

GlobalData on MSN · 3d

Jazz Pharmaceuticals bids for Chimerix in $935m deal

Jazz Pharmaceuticals has announced a definitive agreement to acquire Chimerix, a US-based biotech firm, for approximately $935m in cash. The deal, disclosed on Wednesday 5 March, will see Jazz pay $8.

3don MSN

Jazz Pharmaceuticals to buy Chimerix for $935 million

Jazz Pharmaceuticals will acquire biotech firm Chimerix for about $935 million in cash to gain access to its lead drug ...

Jazz Buys Chimerix - A Good Deal To Make With Major Approval Catalyst In Play

Jazz Pharmaceuticals acquires Chimerix (CMRX) for $935M, adding ONC201, a promising brain cancer drug. Find out why I believe ...

MedCity News3d

First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal

Jazz Pharmaceuticals is now committing $935 million to add this prospect to its pipeline. The drug, dordaviprone, was developed by Durham, North Carolina-based Chimerix. The cancer is H3 K27M ...

Here are highlights from Friday’s Analyst Blog:

Mergers and acquisitions grabbed the spotlight in the biotech sector this week after Jazz Pharmaceuticals announced an ...

Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio

Dordaviprone addresses a significant unmet patient need for patients with rare, high-grade brain tumors--Transaction to add near-term commercial ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results